COMPANY
Lexaria Bioscience Corp.
Funding and NIH signals
- SEC Form D raise Raised $113K (Form D filed Sep 21, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001348362-26-000002 (Sep 21, 2026)
Evidence (2 events)
- Sep 21, 2026 · SEC Form D 0001348362-26-000002
Name of Issuer: Lexaria Bioscience Corp.; CIK: 1348362; Address: British Columbia, Canada; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: 2026-09-09; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 113492; Total Amount Sold: 113492; Federal exemptions: 06b - Dec 19, 2025 · SEC Form D 0001348362-25-000018
Name of Issuer: Lexaria Bioscience Corp.; CIK: 1348362; Address: British Columbia, Canada; Submission type: D; Filing date: 2025-12-19; Industry Group: Biotechnology; Date of First Sale: 2025-12-16; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 3500004; Total Amount Sold: 3500004; Federal exemptions: 06b
- Sep 21, 2026 · SEC Form D 0001348362-26-000002